Patients sue GLP-1 makers over sudden loss of vision
Patients are suing major pharmaceutical companies, including Novo Nordisk and Eli Lilly, claiming that their GLP-1 weight-loss drugs caused sudden vision loss. The patients say the companies did not adequately warn them about the risk of a rare condition that leads to vision loss. One patient, Diane Wirth, lost vision in one eye after taking Wegovy, a GLP-1 drug. The lawsuits are now underway with hundreds of patients involved.
11 across the spectrum · tap a section to jump
The story so far
3 developments- Sep 21Patients sue GLP-1 makers over sudden loss of vision
- Sep 23Only center coverage:Woman details losing vision in 1 eye after taking GLP-1 as hundreds of patients sue drug companies
- Sep 23GLP-1 drugmakers are being sued by patients who suddenly lost their vision
Who covered each development
No new developments
Quiet for 6 daysLast development · Sep 23 — GLP-1 drugmakers are being sued by patients who suddenly lost their vision
Left
2 viewpointsGLP-1 drugmakers are being sued by patients who suddenly lost their vision
Could GLP-1s be linked to a rare type of vision loss? Here’s what to know.
Center
7 viewpointsRight
2 viewpointsOther outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
1 articleCenter
0 articlesNone
Right
0 articlesNone